These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 16627342)
1. Expression of aberrantly glycosylated tumor mucin-1 on human DC after transduction with a fiber-modified adenoviral vector. van Leeuwen EB; Cloosen S; Senden-Gijsbers BL; Agervig Tarp M; Mandel U; Clausen H; Havenga MJ; Duffour MT; García-Vallejo JJ; Germeraad WT; Bos GM Cytotherapy; 2006; 8(1):24-35. PubMed ID: 16627342 [TBL] [Abstract][Full Text] [Related]
2. Transduction with a fiber-modified adenoviral vector is superior to non-viral nucleofection for expressing tumor-associated Ag mucin-1 in human DC. van Leeuwen EB; Cloosen S; Senden-Gijsbers BL; Germeraad WT; Bos GM Cytotherapy; 2006; 8(1):36-46. PubMed ID: 16627343 [TBL] [Abstract][Full Text] [Related]
3. Mucin gene (MUC1) transfer into human dendritic cells by cationic liposomes and recombinant adenovirus. Pecher G; Spahn G; Schirrmann T; Kulbe H; Ziegner M; Schenk JA; Sandig V Anticancer Res; 2001; 21(4A):2591-6. PubMed ID: 11724326 [TBL] [Abstract][Full Text] [Related]
4. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma. Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245 [TBL] [Abstract][Full Text] [Related]
5. Human PBMC-derived dendritic cells transduced with an adenovirus vectorinduce cytotoxic T-lymphocyte responses against a vector-encoded antigen in vitro. Diao J; Smythe JA; Smyth C; Rowe PB; Alexander IE Gene Ther; 1999 May; 6(5):845-53. PubMed ID: 10505110 [TBL] [Abstract][Full Text] [Related]
6. Sensitization to enhanced green fluorescence protein minor histocompatibility antigen by gene transduction into dendritic cells and peritoneal exudate macrophages. Satoh E; Li XK; Hara Y; Ogata K; Guo L; Kitazawa Y; Funeshima-Fuji N; Satoh T; Miyagi T; Sugiura W; Yamamoto N; Teramoto K; Arii S; Kimura H Transpl Immunol; 2007 Nov; 18(2):73-84. PubMed ID: 18005848 [TBL] [Abstract][Full Text] [Related]
7. Expression of tumor-associated differentiation antigens, MUC1 glycoforms and CEA, in human thymic epithelial cells: implications for self-tolerance and tumor therapy. Cloosen S; Arnold J; Thio M; Bos GM; Kyewski B; Germeraad WT Cancer Res; 2007 Apr; 67(8):3919-26. PubMed ID: 17440107 [TBL] [Abstract][Full Text] [Related]
8. Cancer specific Mucin-1 glycoforms are expressed on multiple myeloma. Cloosen S; Gratama J; van Leeuwen EB; Senden-Gijsbers BL; Oving EB; von Mensdorff-Pouilly S; Tarp MA; Mandel U; Clausen H; Germeraad WT; Bos GM Br J Haematol; 2006 Nov; 135(4):513-6. PubMed ID: 17010104 [TBL] [Abstract][Full Text] [Related]
9. Tumor-associated Tn-MUC1 glycoform is internalized through the macrophage galactose-type C-type lectin and delivered to the HLA class I and II compartments in dendritic cells. Napoletano C; Rughetti A; Agervig Tarp MP; Coleman J; Bennett EP; Picco G; Sale P; Denda-Nagai K; Irimura T; Mandel U; Clausen H; Frati L; Taylor-Papadimitriou J; Burchell J; Nuti M Cancer Res; 2007 Sep; 67(17):8358-67. PubMed ID: 17804752 [TBL] [Abstract][Full Text] [Related]
10. Transduction of human dendritic cells with a recombinant modified vaccinia Ankara virus encoding MUC1 and IL-2. Trevor KT; Hersh EM; Brailey J; Balloul JM; Acres B Cancer Immunol Immunother; 2001 Oct; 50(8):397-407. PubMed ID: 11726134 [TBL] [Abstract][Full Text] [Related]
11. Side-by-side comparison of lentivirally transduced and mRNA-electroporated dendritic cells: implications for cancer immunotherapy protocols. Dullaers M; Breckpot K; Van Meirvenne S; Bonehill A; Tuyaerts S; Michiels A; Straetman L; Heirman C; De Greef C; Van Der Bruggen P; Thielemans K Mol Ther; 2004 Oct; 10(4):768-79. PubMed ID: 15451461 [TBL] [Abstract][Full Text] [Related]
13. Mucin-1 is expressed on dendritic cells, both in vitro and in vivo. Cloosen S; Thio M; Vanclée A; van Leeuwen EB; Senden-Gijsbers BL; Oving EB; Germeraad WT; Bos GM Int Immunol; 2004 Nov; 16(11):1561-71. PubMed ID: 15381671 [TBL] [Abstract][Full Text] [Related]
14. Contrasting effects of human, canine, and hybrid adenovirus vectors on the phenotypical and functional maturation of human dendritic cells: implications for clinical efficacy. Perreau M; Mennechet F; Serratrice N; Glasgow JN; Curiel DT; Wodrich H; Kremer EJ J Virol; 2007 Apr; 81(7):3272-84. PubMed ID: 17229706 [TBL] [Abstract][Full Text] [Related]
15. Cross-presentation of a human tumor antigen delivered to dendritic cells by HSV VP22-mediated protein translocation. Chhabra A; Mehrotra S; Chakraborty NG; Mukherji B; Dorsky DI Eur J Immunol; 2004 Oct; 34(10):2824-33. PubMed ID: 15368298 [TBL] [Abstract][Full Text] [Related]
17. Closing the manufacturing process of dendritic cell vaccines transduced with adenovirus vectors. Gulen D; Abe F; Maas S; Reed E; Cowan K; Pirruccello S; Wisecarver J; Warkentin P; Northam M; Turken O; Coskun U; Senesac J; Talmadge JE Int Immunopharmacol; 2008 Dec; 8(13-14):1728-36. PubMed ID: 18793758 [TBL] [Abstract][Full Text] [Related]
18. [Vaccinia virus as a vector for transduction of dendritic cells]. Nĕmecková S; Kutinová L; Hainz P; Subrtová J; Otáhal P; Gabriel P Cas Lek Cesk; 2002 Sep; 141 Suppl():23-5. PubMed ID: 12428418 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the vector systems for gene transduction into rat dendritic cells and peritoneal exudate cells. Satoh E; Hara Y; Fuji N; Li XK; Teramoto K; Arii S; Kimura H Transplant Proc; 2005 May; 37(4):1953-6. PubMed ID: 15919516 [TBL] [Abstract][Full Text] [Related]
20. The influence of N- and O-glycosylation inhibitors on the glycosylation profile of cellular membrane proteins and adhesive properties of carcinoma cell lines. Paszkiewicz-Gadek A; Porowska H; Lemancewicz D; Wolczynski S; Gindzienski A Int J Mol Med; 2006 Apr; 17(4):669-74. PubMed ID: 16525726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]